SPONSOR
Sahlgrenska University Hospital
Total Trials
5
Recruiting
5
Phases
Phase 3
Conditions studied: Hepatic DisordersIntestinal Failure-associated Liver DiseaseCystic Fibrosis Liver DiseaseMAFLDPediatric Liver TransplantationLocally Advanced Pancreatic AdenocarcinomaBorderline Resectable Pancreatic CarcinomaPancreas CancerNeoadjuvant ChemotherapySurgery
Sahlgrenska University Hospital is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Hepatic Disorders, Intestinal Failure-associated Liver Disease, Cystic Fibrosis Liver Disease, MAFLD.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sahlgrenska University Hospital
How many clinical trials has Sahlgrenska University Hospital sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Sahlgrenska University Hospital, of which 5 are actively recruiting participants. These trials cover conditions including Hepatic Disorders, Intestinal Failure-associated Liver Disease, Cystic Fibrosis Liver Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sahlgrenska University Hospital research focus on?
Sahlgrenska University Hospital clinical trials span Hepatic Disorders, Intestinal Failure-associated Liver Disease, Cystic Fibrosis Liver Disease, MAFLD, Pediatric Liver Transplantation, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sahlgrenska University Hospital clinical trial?
To participate in a Sahlgrenska University Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sahlgrenska University Hospital trials with current recruitment status updated daily.
Clinical Trials by Sahlgrenska University Hospital
NCT07202910
Recruiting
VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients
Hepatic Disorders
NCT06714604 Phase 3
Recruiting
Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC
Locally Advanced Pancreatic Adenocarcinoma
NCT07003646
Recruiting
Reperfusion Treatment in Acute Pulmonary Embolism
Pulmonary Embolism
NCT04792892
Recruiting
ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
Anal Cancer
NCT04130971
Recruiting
Predicting Colorectal Cancer - Tissue Samples to Evaluate Tumour Characteristics and Treatment Response
Colorectal Neoplasms
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology